CARI Bengaluru has achieved a significant milestone in quality-assured healthcare under the Ministry of Ayush, as its Clinical Laboratory at the Central Ayurveda Research Institute (CARI), Bengaluru, has been awarded ISO 15189:2022 accreditation for both Biochemistry and Haematology.
With this recognition, CARI Bengaluru becomes the first institute under the Central Council for Research in Ayurvedic Sciences (CCRAS) to secure this distinction.
The ISO 15189:2022 accreditation ensures that CARI Bengaluru delivers accurate, reliable, and safe diagnostic results aligned with globally accepted quality standards.
This achievement marks the laboratory’s transition from an entry-level NABL-certified facility to a fully established, accredited centre of excellence, further strengthening the credibility of CARI Bengaluru in diagnostic and research capabilities.
Prataprao Jadhav, Minister of State (Independent Charge), Ministry of Ayush, highlighted, “Accreditation to international standards such as ISO 15189:2022 ensures that patients receive reliable and precise diagnostic services, which are essential for effective treatment and improved health outcomes.
This achievement by CARI Bengaluru showcases how the Ministry is steadily transforming Ayush infrastructure into a benchmark of quality and reliability.”
Also Read: Ministry of Ayush, DBT Launch Study on Ayurveda for Anti-Tuberculosis Treatment
Vaidya Rajesh Kotecha, Secretary, Ministry of Ayush, added: “The recognition of CARI Bengaluru as the first CCRAS institute with ISO 15189:2022 accreditation in both Biochemistry and Haematology is a landmark step in integrating high-quality diagnostics with traditional systems of medicine. It reinforces our focus on evidence-based practice, research, and patient-centric care.”
Prof. Rabinarayan Acharya, Director General, CCRAS, stated, “The recent NABL accreditation of CARI Bengaluru, building on its earlier NABH and NABL entry-level certifications and ongoing BIS IS/ISO 9001:2015 progression, along with its role as an Ayurveda Science Incubation Centre under the Ministry of Ayush, significantly elevates quality standards, positioning Ayurveda research and innovation at the highest level of scientific rigor and excellence.”
Dr. Sulochana Bhat, Head, CARI, Bengaluru, emphasised, “Achieving ISO 15189:2022 accreditation is a proud milestone for our institute. It reflects our commitment to delivering high-quality, reliable, and patient-centred diagnostic services.
This accomplishment not only strengthens our clinical capabilities but also reinforces our role as a leading institution under CCRAS. This could be achieved due to the sincere efforts of Dr. Vidyashree Anchan (Research Officer, Pathology) and CARI team.”
Currently, CARI Bengaluru holds NABL accreditation for 50 test parameters across Biochemistry and Haematology. The laboratory provides a comprehensive suite of diagnostic services, including blood glucose, HbA1c, liver and kidney function tests, lipid and thyroid profiles, electrolytes, and complete blood counts.
These services enable accurate assessment of metabolic, hormonal, and blood-related conditions, reinforcing the diagnostic strength of CARI Bengaluru.
During 2025–26, CARI Bengaluru conducted over 1.52 lakh investigations, serving more than 9,300 patients. This reflects the institute’s growing capacity and commitment to delivering high-quality diagnostics.
Equipped with advanced systems and digital reporting tools, patients at CARI Bengaluru benefit from faster turnaround times, enhanced accuracy, and convenient access to reports via SMS, email, and WhatsApp.
The growth trajectory of CARI Bengaluru across clinical, research, and diagnostic services further underscores its achievement. OPD footfall has more than doubled from 18,918 in 2021 to over 51,300 in 2026, reflecting increasing public trust.
Laboratory investigations have surged from 2,770 tests in 2021 to over 1.55 lakh in 2026, highlighting enhanced diagnostic capacity at CARI Bengaluru.
Panchakarma and para-surgical procedures have expanded nearly twentyfold, while research activities have remained robust with around 20–25 projects annually.
Also Read: Union Budget 2026–27 Proposes Regional Medical Hubs to Boost Medical Value Tourism
Since the introduction of inpatient services in July 2024, CARI Bengaluru has recorded nearly full bed occupancy, indicating rising demand for integrative healthcare. The institute has also strengthened its role in medicinal plant validation, significantly scaling up authentication efforts over the years.
The journey towards this milestone reflects sustained institutional commitment. Starting with a single semi-automated biochemistry analyser, the laboratory was progressively upgraded with fully automated systems under the Centre of Excellence Scheme of the Ministry of Ayush.
CARI Bengaluru: Meeting Stringent ISO 15189:2022 Standards Through Rigorous Quality Implementation, Documentation, and Assessment
The laboratory at CARI Bengaluru plays a critical role in supporting Ayurveda and Ayush-based treatments by providing dependable diagnostic data for clinical decision-making, monitoring patient progress, and strengthening research outcomes.
Notably, CARI Bengaluru had earlier become the first CCRAS institute to secure both NABH and NABL entry-level certifications during 2021–22 and is progressing towards BIS IS/ISO 9001:2015 certification. This continued advancement reinforces the institute’s commitment to quality, precision, and excellence.
Looking ahead, the institute plans to expand its range of accredited tests and further enhance diagnostic capabilities, aiming to deliver more comprehensive, accessible, and affordable healthcare services to the public.
